Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVDX | Common Stock | Options Exercise | $718K | +352K | $2.04 | 352K | Oct 15, 2021 | By QED Fund III, L.P. | F1 | |
transaction | AVDX | Common Stock | Tax liability | -$718K | -28.7K | -8.16% | $25.00 | 323K | Oct 15, 2021 | By QED Fund III, L.P. | F1 |
transaction | AVDX | Common Stock | Conversion of derivative security | +891K | +275.53% | 1.21M | Oct 15, 2021 | By QED Fund III, L.P. | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVDX | Warrant (right to buy) | Options Exercise | $0 | -352K | -100% | $0.00* | 0 | Oct 15, 2021 | Common Stock | 352K | $2.04 | By QED Fund II, L.P. | F3 |
transaction | AVDX | Series E Preferred Stock | Conversion of derivative security | $0 | -223K | -100% | $0.00* | 0 | Oct 15, 2021 | Common Stock | 891K | By QED Fund II, L.P. | F2 |
Id | Content |
---|---|
F1 | In connection with the issuer's initial public offering of common stock, these warrants were automatically converted into shares of the issuer's common stock on a net exercise basis. |
F2 | In connection with the issuer's initial public offering of common stock, all shares of Series E Preferred Stock were automatically converted into shares of the issuer's common stock on a 4-for-1 basis. The preferred stock was perpetual and therefore had no expiration date. |
F3 | The number of underlying shares of common stock and the exercise price reflect the 4-for-1 forward stock split which was effected on September 30, 2021. |